Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sotera Health (SHC) Current Deferred Revenue (2020 - 2025)

Historic Current Deferred Revenue for Sotera Health (SHC) over the last 6 years, with Q3 2025 value amounting to $14.1 million.

  • Sotera Health's Current Deferred Revenue rose 3177.57% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year increase of 3177.57%. This contributed to the annual value of $15.1 million for FY2024, which is 1185.19% up from last year.
  • Latest data reveals that Sotera Health reported Current Deferred Revenue of $14.1 million as of Q3 2025, which was up 3177.57% from $11.5 million recorded in Q2 2025.
  • In the past 5 years, Sotera Health's Current Deferred Revenue registered a high of $15.2 million during Q1 2023, and its lowest value of $4.9 million during Q3 2021.
  • For the 5-year period, Sotera Health's Current Deferred Revenue averaged around $11.0 million, with its median value being $12.7 million (2023).
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 13774.08% in 2023, then plummeted by 1582.76% in 2024.
  • Over the past 5 years, Sotera Health's Current Deferred Revenue (Quarter) stood at $8.7 million in 2021, then surged by 39.54% to $12.1 million in 2022, then rose by 11.2% to $13.5 million in 2023, then grew by 11.85% to $15.1 million in 2024, then dropped by 6.62% to $14.1 million in 2025.
  • Its last three reported values are $14.1 million in Q3 2025, $11.5 million for Q2 2025, and $13.8 million during Q1 2025.